Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Cytopenia × cedazuridine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 2 Melanoma 1 Cytopenia 1

Interventions

AP 1903 reagent 2 cedazuridine 1 ON 01910 1 Interleukin-8 1 HuMax-IL8 1 Decitabine 1 DNA 1 Cord Blood Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05148234 2025-09-30

BMS-986253 in Myelodysplastic Syndromes

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated

2 enrolled 11 charts

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡